Literature DB >> 21472888

Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathologic development of oral cancer.

Ming-Hsien Chien1, Lin Shih-Shen Chou, Tsung-Te Chung, Chien-Huang Lin, Ming-Yung Chou, Meng-Shih Weng, Shun-Fa Yang, Mu-Kuan Chen.   

Abstract

BACKGROUND: This study investigates the association between polymorphism in the E-cadherin/CDH1 promoter region and the risk and progression of oral cancer.
METHODS: Genetic polymorphisms of CDH1-160 and -347 were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 347 noncancer controls and in 251 patients with oral cancer.
RESULTS: The statistical analysis showed that subjects with at least 1 varied GA allele of CDH1-347 polymorphic genotypes or combinations of the CDH1-160 CA/-347 GGA, CDH1-160 CC/-347 GGA, or CDH1-160 CC/-347 GAGA genotypes had a significantly higher risk, whereas subjects with CDH1-160 C/A or A/A had a significantly lower risk of developing oral cancer than those with wild-type genotypes. Furthermore, elderly patients with the CDH1-347 G/GA or GA/GA genotype were associated with a higher incidence in lymph node metastasis than were those with the G/G genotype.
CONCLUSIONS: These results suggest that CDH1-347 polymorphisms are associated with increased risks of oral cancer, and may be a predictive factor for tumor lymph node metastasis.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21472888     DOI: 10.1002/hed.21746

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  9 in total

1.  E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.

Authors:  Yadong Wang; Haiyan Yang; Li Li; Haiyu Wang; Congke Zhang; Xiangqun Xia
Journal:  Int J Colorectal Dis       Date:  2011-10-14       Impact factor: 2.571

Review 2.  Genetic alterations and clinical dimensions of oral cancer: a review.

Authors:  Keerthana Karunakaran; Rajiniraja Muniyan
Journal:  Mol Biol Rep       Date:  2020-10-21       Impact factor: 2.316

3.  Contribution of the -160C/A polymorphism in the E-cadherin promoter to cancer risk: a meta-analysis of 47 case-control studies.

Authors:  Lin Wang; Guiying Wang; Chenqi Lu; Bo Feng; Jiuhong Kang
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

4.  Expression of E- Cadherin and Levels of Dysplasia in Oral Leukoplakia - A Prospective Cohort Study.

Authors:  I Ilangani Sathish; Kannan Asokan; Krithika C L; Arvind Ramanathan
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01

5.  Clinical significance of altered expression of β-catenin and E-cadherin in oral dysplasia and cancer: potential link with ALCAM expression.

Authors:  Jatinder Kaur; Meenakshi Sawhney; Siddhartha DattaGupta; Nootan Kumar Shukla; Anurag Srivastava; Paul G Walfish; Ranju Ralhan
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

6.  Epithelial-Mesenchymal Transition during Metastasis of HPV-Negative Pharyngeal Squamous Cell Carcinoma.

Authors:  Friedrich Ihler; Ronja Gratz; Hendrik A Wolff; Bernhard G Weiss; Mattis Bertlich; Julia Kitz; Gabriela Salinas; Margret Rave-Fränk; Martin Canis
Journal:  Biomed Res Int       Date:  2018-03-06       Impact factor: 3.411

7.  Correlation of E-cadherin gene polymorphisms and epidermal growth factor receptor mutation in lung adenocarcinoma.

Authors:  Chun-Yao Huang; Ming-Ju Hsieh; Tu-Chen Liu; Whei-Ling Chiang; Ming-Che Liu; Shun-Fa Yang; Thomas Chang-Yao Tsao
Journal:  Int J Med Sci       Date:  2018-05-22       Impact factor: 3.738

8.  Carbonic Anhydrase III Promotes Cell Migration and Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma.

Authors:  Yin-Hung Chu; Chun-Wen Su; Yih-Shou Hsieh; Pei-Ni Chen; Chiao-Wen Lin; Shun-Fa Yang
Journal:  Cells       Date:  2020-03-13       Impact factor: 6.600

9.  Differences in Extracellular Vesicle Protein Cargo Are Dependent on Head and Neck Squamous Cell Carcinoma Cell of Origin and Human Papillomavirus Status.

Authors:  Christine Goudsmit; Felipe da Veiga Leprevost; Venkatesha Basrur; Lila Peters; Alexey Nesvizhskii; Heather Walline
Journal:  Cancers (Basel)       Date:  2021-07-23       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.